HIV blood study to study immune responses over many years
Part of Immune system & allergy, Infections clinical trials.
This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to under 80 years old and have a confirmed HIV-1 diagnosis
- Be able and willing to sign written consent and have blood drawn for storage
- Be on HIV treatment with very low viral load for the required time in either the short-term or long-term group
- You must have had regular viral load checks at least once each year
- You should not have had AIDS-related opportunistic infections in the past or currently
- Avoid pregnancy or breastfeeding, and have blood tests (hemoglobin, platelets, neutrophils, liver tests) above safety cutoffs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood samples from people living with HIV to study dormant (inactive) HIV cells in the lab. The goal is to better understand how to target these hidden cells as part of an eventual cure.
This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.
This study looks at why HIV remains in the body even when treatment is working well. You would have a colonoscopy (already scheduled for medical reasons) and allow the research team to take extra tissue samples to study how the virus hides in the gut.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This study follows people with a very recent HIV infection and collects blood and other samples to learn more about the infection soon after it starts. It may help researchers better understand early HIV and improve future treatments.
This study looks closely at how your immune system and HIV infection markers change right after a new HIV diagnosis. It may help doctors understand the earliest stages of HIV and improve how infections are measured and followed over time.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.